Filter
559
Filtered Results: 559
Text search:
Trachoma
Featured
Recommendations
63
New Publications
159
Language
Document type
No document type
285
Studies & Reports
90
Guidelines
80
Strategic & Response Plan
41
Manuals
25
Fact sheets
17
Training Material
6
Dashboards/Maps
4
Situation Updates
3
Online Courses
3
Brochures
2
Infographics
2
Videos
1
Countries / Regions
Global
40
Ethiopia
21
Nepal
16
Africa
16
India
12
Tanzania
11
Uganda
11
Burkina Faso
10
Kenya
9
Ghana
9
Senegal
9
Latin America and the Carribbean
9
Malawi
7
Mozambique
7
Liberia
7
Benin
6
Cameroon
6
Congo, Democratic Republic of
6
Nigeria
5
Paraguay
5
South Africa
5
Myanmar / Burma
5
Sierra Leone
4
West and Central Africa
4
East and Southern Africa
4
Bangladesh
4
Zambia
4
Rwanda
3
Niger
3
Germany
3
Central African Republic
3
Indonesia
3
Ukraine
2
Lesotho
2
Burundi
2
Zimbabwe
2
Philippines
2
Middle East and North Africa
2
Argentina
2
Yemen
2
Angola
2
Botswana
2
South Sudan
2
Eswatini/ Swaziland
2
Colombia
1
Syria
1
Iran
1
Afghanistan
1
Qatar
1
Mauritania
1
Asia
1
Guinea-Bissau
1
Jordan
1
Saudi Arabia
1
South–East Asia Region
1
Western and Central Europe
1
Lebanon
1
Brazil
1
Russia
1
Djibouti
1
Namibia
1
Egypt
1
Sudan
1
Palestine
1
Libya
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
209
Clinical Guidelines
70
Public Health
39
Key Resources
31
Women & Child Health
23
Capacity Building
9
Pharmacy & Technologies
4
Toolboxes
NTDs
90
HIV
26
Disability
26
Planetary Health
23
Pharmacy
22
AMR
17
Caregiver
16
Global Health Education
11
Rapid Response
10
Refugee
9
NCDs
9
COVID-19
8
Natural Hazards
7
Mental Health
3
TB
3
Cholera
3
Ebola
3
Conflict
3
WHO Fact sheets, questions and answers.
Trachoma is a disease of the eye and the leading infectious cause of blindness worldwide.
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
Surveys are needed to guide trachoma control efforts in Mozambique, with WHO guidelines for intervention based on the prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years and the prevalence of trichiasis in adults aged 15 years and above. We conducted surveys to com...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
In order to target resources and drugs to reach trachoma elimination targets by the year 2020, data on the burden of disease are required. Using prevalence data in African countries derived from the Global Atlas of Trachoma (GAT), the distribution of trachoma continues to be focused in East and West...
Trachoma Atlas is dedicated to eliminating the world's leading infectious cause of preventable blindness
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
The Fifty-first World Health Assembly,
Recalling resolutions WHA22.29, WHA25.55 and WHA28.54 on the prevention of blindness, and
WHA45.10 on disability prevention and rehabilitation;
Aware of previous efforts and progress made in the global fight against infectious eye diseases, in particular
tr...
Trachoma is one of the 17 WHO-defined Neglected Tropical Diseases
(NTDs) that affect over 1 billion of the world’s poorest and most
marginalized people. It is caused by the bacterium chlamydia trachomatis.
Trachoma is an eye infection affecting both eyes. It is the world’s leading cause of infectious blindness. A bacterium called Chlamydia trachomatis causes trachoma. According to the World Health Organization (WHO), trachoma has caused the visual impairment of 1.8 million people. Of those people, 4...
This manual is designed to provide specific information for trachomatous trichiasis (TT) trainers who are training others to undertake surgery for entropion trachomatous trichiasis (TT). Other approaches are not addressed. The manual is divided into two parts. The first part covers specifics designe...
